Sun Pharma Q1 net loss at ₹1,655.50 cr

PTI New Delhi | Updated on July 31, 2020 Published on July 31, 2020

Drug major Sun Pharmaceutical Industries on Friday reported a consolidated net loss of ₹1,655.60 crore for the quarter ended June 30, 2020. The company had posted a net profit of ₹1,387.48 crore for the corresponding period of the previous fiscal.

The company’s consolidated revenue from operations stood at ₹7,585.25 crore for the quarter as against ₹8,374.36 crore for the same period year ago.

Shares of Sun Pharmaceutical Industries closed at ₹531.75 on the BSE, up 4.27 per cent over previous close.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on July 31, 2020
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.